HOME >> MEDICINE >> NEWS
AstraZeneca announces SYMBICORT is now available in the US

Wilmington, Del. June 25, 2007 -- AstraZeneca announced today that SYMBICORT (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available in the United States for the long-term maintenance treatment of asthma in patients 12 years of age and older.

Administered twice daily, SYMBICORT is a combination of two proven asthma medications budesonide, an inhaled corticosteroid (ICS), and formoterol, a rapid and long-acting beta2-agonist (LABA). For many patients, this combination treatment offers improved asthma control as early as day one that is sustained over 12 weeks. SYMBICORT also delivers improved lung function occurring within 15 minutes of beginning treatment. SYMBICORT does not replace fast-acting inhalers for sudden attacks.

SYMBICORT is available in two dose strengths, 80/4.5 and 160/4.5 mcg of budesonide and formoterol, respectively. SYMBICORT is approved for patients whose disease is not adequately controlled on another asthma-controller medication (e.g., low- to medium-dose inhaled corticosteroids) or whose disease severity clearly warrants initiation of treatment with two maintenance therapies.

With the U.S. launch of SYMBICORT, millions of asthma sufferers will have a new choice of fixed combination therapy to help achieve control of their asthma, said Chris OBrien, MD, PhD, senior director, Medical Science, AstraZeneca.

Asthma is one of the most serious chronic diseases in the U.S. It is estimated that more than 20 million Americans suffer from the condition and, if not properly managed, asthma can be life-threatening.

The U.S. availability of SYMBICORT holds great promise for millions of Americans that suffer from asthma, said Tony Zook, president and chief executive officer, AstraZeneca U.S. The addition of SYMBICORT to our respiratory portfolio reinforces AstraZenecas commitment to developing new, effective treatments, and provides patients and physicians
'"/>

Contact: Tracy Knudsen
Tracy.Knudsen@astrazeneca.com
302-885-1933
AstraZeneca
25-Jun-2007


Page: 1 2

Related medicine news :

1. AstraZeneca, University of Miami, and Humana collaborate to improve consumer health
2. AstraZeneca and M. D. Anderson Cancer Center form umbrella scientific collaboration agreements
3. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
4. Weill Cornell Medical College announces gifts totaling $400M
5. GSK announces launch of largest ever Phase III trial in lung cancer treatment
6. Elsevier announces launch of Brain Stimulation
7. NSW Premier announces $15M for childrens cancer research
8. National Inventors Hall of Fame announces 2007 inductees
9. Emory University announces new Global Health Institute
10. BioMed Central announces Journal of Medical Case Reports
11. Tibotec Therapeutics announces start of largest US study on HIV treatment in women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AstraZeneca announces SYMBICORT now available the

(Date:3/26/2015)... U.S. medical real estate sales ... according to an exclusive new report now available ... estate (HRE) data firm also announced that it ... Gold-Level Partners: Harrison Street Real Estate Capital and ... still going strong, yields compressed, prices per square ...
(Date:3/26/2015)... 26, 2015 Pacific Medical LLC, the ... to be featured on Innovations with Ed Begley Jr, ... 2015. The episode will repeat on local cable ... the Pacific Medical home page at: http://www.pacificmedicalsupply.com . ... it is reassuring to trust the integrity of the ...
(Date:3/26/2015)... 2015 On March 5, 2015, Portland ... out for the season with a torn Achilles tendon ... Trail Blazers were competing against Dallas, and was confirmed ... Izzy Silva, M.D., who has treated many professional athletes, ... it could be prevented. , "Part of the ...
(Date:3/26/2015)... In the key developed markets, the hypertension market value reached ... decrease through 2020 at a negative CAGR (0.9%) to USD ... 2017 at a 2.6% CAGR and a decline thereafter. The ... penetration of fixed-dose combination drugs like Azor, Amturnide, Exforge Tribenzor, ... Tekamlo), a hike in the prevalence population to 190 million ...
(Date:3/26/2015)... Texas (PRWEB) March 26, 2015 In ... organization Health Fitness Revolution, founded by Samir Becic, has ... on their own personal health and fitness, as well ... political agenda. The list includes Sen. Ted Cruz, who ... as well as all other politicians who have shown ...
Breaking Medicine News(10 mins):Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3
(Date:3/26/2015)... 26, 2015 Cardiologists at Beaumont Hospital, ... first commercial implant of a device recently approved by ... atrial fibrillation. The Watchman Left Atrial Appendage Closure implant ... medication to reduce the risk of stroke. ... affecting more than 5 million Americans. Twenty percent of ...
(Date:3/26/2015)... Over-the-counter healthcare costs can be a ... new survey of store brand over-the-counter products aimed ... to diabetes, can offer significant savings for those ... Private Label Manufacturers Association, assembled a market basket ... essential for treatment of pre-diabetes and diabetes. These ...
(Date:3/26/2015)... LAS VEGAS , March 26, 2015 ... its Vivacit-E ® Advanced Bearing Technology ... A paper published earlier this month reported ... testing, Vivacit-E Advanced Bearing Technology featuring Vitamin ... Zimmer maintained a significant wear rate reduction of 95 ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Consumers can keep over-the-counter medicine affordable by using store brands 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
Cached News: